Go to deals
Consumer & Retail

SwissEdilab has sold the brands Colon Pure & Ail Noir Oxyprotect to Noreva Pharma

SwissEdilab, a firm specialized in distribution of food supplements, has sold the brands Colon Pure and Ail Noir Oxyprotect to Noreva Pharma.

Noreva Pharma is a French cosmetics laboratory specialized in the development of dermatological care products distributed in drug stores.
This strategic acquisition expands the firm's product range distributed by its sales force. Noreva Pharma, which is very active in the OTC health market in France, had already acquired Phythea in 2016 and the Bergasol brand from Omega Pharma in 2018.

Oaklins' team in France was the sell-side advisor for SwissEdilab in this transaction.

Service
M&A sell-side
Parties

Talk to the deal team

 Ludovic  Beaulieu

Ludovic Beaulieu

Partner

Paris, France
Oaklins France

Related deals

Alon Blue Square Israel has issued bonds worth US$81 million
Consumer & Retail

Alon Blue Square Israel has issued bonds worth US$81 million

Alon Blue Square Israel Ltd. has completed a fundraising to refinance and develop the company.

Learn more
Pokawa has signed a partnership with Vendis Capital
Private Equity | Consumer & Retail | Food & Beverage

Pokawa has signed a partnership with Vendis Capital

Pokawa has signed a strategic agreement with its new partner Vendis Capital.

Learn more
Mutigny Resort Hotel has raised funds to construct a new 4-star hotel in Champagne
Consumer & Retail | Real Estate

Mutigny Resort Hotel has raised funds to construct a new 4-star hotel in Champagne

Mutigny Resort Hotel (MRH) has raised funds to construct a new 4-star hotel in Champagne. This involved agreements with the promoter, Artec Groupe, the operator, Loisium Wine & Spa Hotels, bank debt with Caisse d'Epargne Grand-Est Europe, Banque Postale and Arkea, and equity with La Banque des territoires, Merimee and Artec Groupe.

Learn more